288.1 🎓 醫孞生版

288.1.0.1 📌 䞀頁重點

288.1.0.1.1 Atrial Septal Defect (ASD)
288.1.0.1.1.1 Types (Anatomic Locations)
  1. Ostium secundum (70%): middle of septum (foramen ovale region) — most common; closes via percutaneous device
  2. Ostium primum (15-20%): low septum near AV valves (partial AVSD); requires surgical repair; associated with mitral cleft
  3. Sinus venosus (5-10%): near SVC or IVC entry; often with anomalous pulmonary venous return; surgical
  4. Coronary sinus (< 1%): unroofed coronary sinus; rare
288.1.0.1.1.2 Pathophysiology
  • L→R shunt at atrial level (LA → RA via defect)
  • Volume overload of RA + RV → RA/RV dilation
  • ↑ pulmonary blood flow → eventual pulmonary HTN (slower than VSD/PDA)
  • AF common in adults (LA + RA dilation)
  • Eisenmenger uncommon (only ~ 10% of unrepaired large ASD)
288.1.0.1.1.3 Clinical Presentation
  • Asymptomatic through childhood and young adulthood
  • 3rd-4th decade onset of symptoms: dyspnea, fatigue, palpitations
  • AF common adult presentation
  • Paradoxical embolism / stroke
  • Recurrent pulmonary infections
288.1.0.1.1.4 Examination
  • Fixed split S2 (classic — S2 doesn’t vary with respiration)
  • Soft systolic ejection murmur at L upper sternal border (relative pulmonic stenosis from ↑ flow)
  • Mid-diastolic rumble at L lower sternal border (relative tricuspid stenosis from ↑ flow)
  • RV heave
  • Loud P2 if PH
288.1.0.1.1.5 ECG
  • Right axis deviation
  • Incomplete RBBB (typical secundum)
  • Left axis deviation + first-degree AV block (ostium primum)
  • RAE, RVH (advanced)
  • AF (adults)
288.1.0.1.1.6 CXR
  • Cardiomegaly (RA + RV)
  • Increased pulmonary vasculature (shunt vascularity)
  • “Snowman” sign (TAPVR — total anomalous pulmonary venous return)
288.1.0.1.1.7 Echo
  • Defect visualization (2D + color Doppler)
  • Bubble study (agitated saline): RA bubbles → LA (R→L flow with Valsalva release)
  • Pulmonary HTN assessment
  • RV function
288.1.0.1.1.8 TEE
  • Definitive for ASD type, size, surrounding structures
  • Critical for percutaneous closure planning
288.1.0.1.1.9 Treatment

Closure Indications - Hemodynamically significant ASD: RA/RV dilation, Qp:Qs > 1.5:1 - Paradoxical embolism (cryptogenic stroke) - Exercise intolerance - Pulmonary HTN (early/moderate, not Eisenmenger) - AF - Decompensated HF (controversial)

Closure Contraindications - Eisenmenger syndrome (PVR > SVR, R→L shunt) — absolute - Severe pulmonary HTN with reactive vasculature debatable

Methods - Percutaneous device closure (Amplatzer septal occluder) — first-line for ostium secundum - Surgical closure for ostium primum, sinus venosus, coronary sinus, or complex anatomy - AC + DAPT for 6 months post-percutaneous

288.1.0.1.2 Ventricular Septal Defect (VSD)
288.1.0.1.2.1 Types
  1. Perimembranous (80%): most common; in membranous septum
  2. Muscular (5-20%): in muscular septum; often multiple
  3. Inlet (5%): AV canal type (AVSD)
  4. Outlet (subaortic, supracristal, 5%): high; AR risk
  5. Doubly committed subarterial (Asian populations)
288.1.0.1.2.2 Pathophysiology
  • L→R shunt at ventricular level (LV → RV via defect)
  • Magnitude depends on defect size + PVR
  • Small (restrictive): high gradient, small shunt → minimal hemodynamic consequence
  • Moderate-large: significant shunt → LV volume overload → HF, PH
  • Most VSDs close spontaneously in childhood (75% by 10 yo, especially small muscular)
  • Adult unrepaired large VSD → Eisenmenger common
288.1.0.1.2.3 Clinical Presentation
  • Small VSD: asymptomatic (Roger’s murmur)
  • Moderate-large: HF symptoms, exercise intolerance
  • Adult unrepaired: Eisenmenger (cyanosis, polycythemia)
288.1.0.1.2.4 Examination
  • Holosystolic harsh murmur at L lower sternal border (3rd-4th ICS)
  • Thrill (large defect)
  • Loud P2 if PH
  • S3, signs of HF
288.1.0.1.2.5 ECG
  • Small VSD: normal
  • Large: LAE, LVH, biventricular hypertrophy with PH
288.1.0.1.2.6 Echo
  • Defect visualization, size, location
  • Doppler gradient
  • LV/LA size, function
  • PH assessment
  • Aortic regurgitation (associated with subaortic VSD)
288.1.0.1.2.7 Treatment

Closure Indications - Symptomatic with significant shunt (Qp:Qs > 1.5) - LV volume overload - Aortic regurgitation (subaortic VSD) - Prior IE - Pulmonary HTN (early, before Eisenmenger)

Closure Methods - Surgical patch (gold standard) for perimembranous, inlet, outlet - Transcatheter device closure for muscular VSD or post-MI VSD (now expanding indication)

Post-MI VSD - Mechanical complication (Ch273) - Acute, devastating - Emergent surgical or transcatheter repair - IABP, ECMO bridge

288.1.0.1.3 Patent Ductus Arteriosus (PDA)
288.1.0.1.3.1 Embryology
  • Fetal: ductus connects pulmonary artery to descending aorta (bypasses fetal lungs)
  • Closes within days postnatal (functional) → fibroses (anatomic, weeks-months)
  • Failure to close: PDA
  • Prematurity, hypoxia, prostaglandins (E2) keep open
288.1.0.1.3.2 Pathophysiology
  • L→R shunt at level of great arteries (aorta → pulmonary)
  • Continuous “machine” murmur
  • Variable severity: small to massive
  • Untreated → Eisenmenger
  • Eisenmenger: reversed shunt → cyanosis of lower body only (R→L below ductus)
288.1.0.1.3.3 Clinical Presentation
  • Small PDA: asymptomatic
  • Moderate-large: HF, exercise intolerance
  • Eisenmenger: cyanosis + clubbing of lower extremities; pink upper body
288.1.0.1.3.4 Examination
  • Continuous “machinery” murmur at L upper chest, beneath L clavicle
  • Wide pulse pressure, bounding pulses
  • Eisenmenger PDA: differential cyanosis (cyanotic + clubbed feet, normal arms)
288.1.0.1.3.5 ECG
  • Normal (small)
  • LV/LA enlargement (large)
  • RV hypertrophy if PH
288.1.0.1.3.6 Echo
  • Direct visualization, color Doppler from PA into descending aorta
288.1.0.1.3.7 Treatment

Closure Indications - Hemodynamically significant - Prior IE - LV volume overload, PH

Closure Methods - Percutaneous coil / device — first-line for most - Surgical ligation for very large or complex

Pharmacologic Closure (Neonates) - Indomethacin or ibuprofen in premature infants - Definitive in many cases

288.1.0.1.4 Patent Foramen Ovale (PFO)
288.1.0.1.4.1 Background
  • 25-30% of adults have PFO (vs ASD = pathologic defect)
  • Usually clinically silent
  • Small R→L shunt possible during Valsalva
288.1.0.1.4.2 Clinical Significance
  • Cryptogenic stroke in young: paradoxical embolism via PFO
  • Migraine with aura (debated)
  • Decompression sickness in divers
  • Platypnea-orthodeoxia syndrome
288.1.0.1.4.3 Diagnosis
  • Bubble study (agitated saline) during Valsalva release
  • TEE definitive (anatomy, size, atrial septal aneurysm)
288.1.0.1.4.4 PFO Closure for Cryptogenic Stroke

Key Trials: - CLOSURE I (2012) — neg (Starflex device) - PC trial (2013) — neg (Amplatzer) - RESPECT (2013, extended 2017) — PFO closure reduces recurrent stroke - CLOSE (2017) — PFO closure + antiplatelet > antiplatelet alone (especially if atrial septal aneurysm or large shunt) - DEFENSE-PFO (2018) — Korean — confirmed benefit - RESPECT extended (2017) — long-term benefit

Patient Selection (2024 ACC/AHA) - Age < 60 (selected 60-65) - Cryptogenic stroke (CRYPTOGENIC, not from other source) - PFO with paradoxical embolism mechanism (RoPE score) - ASA or NOAC alone vs PFO closure

Procedure: Percutaneous device, ASA + clopidogrel post-procedure

288.1.0.1.5 Atrioventricular Septal Defect (AVSD / Endocardial Cushion)
  • AKA “AV canal defect”
  • Failure of endocardial cushion fusion → ostium primum ASD + inlet VSD + common AV valve
  • Down syndrome strongly associated (40-50% of T21 with CHD)
  • Partial AVSD (ostium primum + cleft MV) vs complete AVSD (large VSD + common AV valve)
  • Treatment: surgical repair in infancy
  • Adult issues: MR (residual mitral cleft), arrhythmia, HF
288.1.0.1.6 Anomalous Pulmonary Venous Return
  • Total Anomalous Pulmonary Venous Return (TAPVR): all 4 pulmonary veins to systemic
    • Supracardiac (most common): to L vertical vein → innominate
    • Cardiac: to coronary sinus or RA
    • Infradiaphragmatic: to portal vein
    • Mixed
  • Partial Anomalous Pulmonary Venous Return (PAPVR):
    • One or more PV → systemic
    • Right upper PV to SVC common (often with sinus venosus ASD)
    • “Scimitar syndrome” = right PV to IVC + R lung hypoplasia + dextroposition
  • Treatment: surgical re-routing in infancy/childhood

288.1.0.2 🩺 床邊速查

  • ASD: secundum most common; fixed split S2; percutaneous closure for secundum
  • VSD: perimembranous most common; holosystolic at LLSB; surgical repair preferred
  • PDA: continuous “machinery” murmur; percutaneous coil
  • PFO closure: cryptogenic stroke < 60 yo (CLOSE, RESPECT, DEFENSE-PFO)
  • Eisenmenger: absolute contraindication to shunt closure